Search research articles
Contact Us
Filters
Showing results (11-20 of 41) with videos related to
Page
of 5
Sort By:
Journal of Chromatography. A
|
January 22, 2025
Analysis of partly bio-derived nonionic polyethylene glycol-based rheology modifiers by comprehensive two-dimensional liquid chromatography
Meng Jing, Wenshiue Young, Kathleen Michels, et al.
Cancer Biology & Therapy
|
June 23, 2026
Efficacy and safety profiles of CDK4/6 inhibitor in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (ABC) from the high-altitude <i>versus</i> low-altitude regions: a multi-center retrospective study
Yujing Tan, Yinyin Ye, Weihong Zhao, et al.
Breast Cancer (Dove Medical Press)
|
June 29, 2026
Efficacy of CDK4/6 Inhibitor Plus Aromatase Inhibitor versus Fulvestrant in Chinese Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer
Yujing Tan, Cheng Zeng, Jiuda Zhao, et al.
Computational and Mathematical Methods in Medicine
|
December 25, 2019
Differentiation of Recurrence from Radiation Necrosis in Gliomas Based on the Radiomics of Combinational Features and Multimodality MRI Images
Quan Zhang, Jianyun Cao, Junde Zhang, et al.
Journal of Nutrition and Metabolism
|
September 25, 2025
Novel Causal Evidence for the Role of Circulating Lipid Metabolites in Breast Cancer Risk: A Bidirectional Mendelian Randomization Analysis
Cheng Zeng, Shuning Liu, Yuhan Wei, et al.
Oral Oncology
|
January 26, 2025
β-eudesmol inhibits cell growth and enhances cell chemosensitivity of NPC through targeting FGF1/FGFR signaling
Tao Xie, Yuqi Shu, Wei Huang, et al.
Aging
|
May 3, 2024
Unraveling the unfolded protein response signature: implications for tumor immune microenvironment heterogeneity and clinical prognosis in stomach cancer
Wenhao Ouyang, Yajing Liu, Hong Huang, et al.
The Oncologist
|
May 23, 2024
Adjuvant treatment strategy evolution and risk stratification for hormone receptor-positive, human epidermal growth factor receptor-2 negative early breast cancer in China
Ying Fan, Danyang Ji, Mingxia Jiang, et al.
Acta Biomaterialia
|
July 11, 2025
Structural adaptations of curved-stem moso bamboo: tissue specialization for resilience under mechanical stress
Jianyi Zhu, Kaiwen Chen, Wenjuan Zhao, et al.
Annals of Translational Medicine
|
March 17, 2020
PITPNC1 fuels radioresistance of rectal cancer by inhibiting reactive oxygen species production
Yujing Tan, Ruoyang Shao, Jingyu Li, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 41) with videos related to
Sort By:
Page
of 5
Journal of Chromatography. A
|
January 22, 2025
Analysis of partly bio-derived nonionic polyethylene glycol-based rheology modifiers by comprehensive two-dimensional liquid chromatography
Meng Jing, Wenshiue Young, Kathleen Michels, et al.
Cancer Biology & Therapy
|
June 23, 2026
Efficacy and safety profiles of CDK4/6 inhibitor in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer (ABC) from the high-altitude <i>versus</i> low-altitude regions: a multi-center retrospective study
Yujing Tan, Yinyin Ye, Weihong Zhao, et al.
Breast Cancer (Dove Medical Press)
|
June 29, 2026
Efficacy of CDK4/6 Inhibitor Plus Aromatase Inhibitor versus Fulvestrant in Chinese Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Advanced Breast Cancer
Yujing Tan, Cheng Zeng, Jiuda Zhao, et al.
Computational and Mathematical Methods in Medicine
|
December 25, 2019
Differentiation of Recurrence from Radiation Necrosis in Gliomas Based on the Radiomics of Combinational Features and Multimodality MRI Images
Quan Zhang, Jianyun Cao, Junde Zhang, et al.
Journal of Nutrition and Metabolism
|
September 25, 2025
Novel Causal Evidence for the Role of Circulating Lipid Metabolites in Breast Cancer Risk: A Bidirectional Mendelian Randomization Analysis
Cheng Zeng, Shuning Liu, Yuhan Wei, et al.
Oral Oncology
|
January 26, 2025
β-eudesmol inhibits cell growth and enhances cell chemosensitivity of NPC through targeting FGF1/FGFR signaling
Tao Xie, Yuqi Shu, Wei Huang, et al.
Aging
|
May 3, 2024
Unraveling the unfolded protein response signature: implications for tumor immune microenvironment heterogeneity and clinical prognosis in stomach cancer
Wenhao Ouyang, Yajing Liu, Hong Huang, et al.
The Oncologist
|
May 23, 2024
Adjuvant treatment strategy evolution and risk stratification for hormone receptor-positive, human epidermal growth factor receptor-2 negative early breast cancer in China
Ying Fan, Danyang Ji, Mingxia Jiang, et al.
Acta Biomaterialia
|
July 11, 2025
Structural adaptations of curved-stem moso bamboo: tissue specialization for resilience under mechanical stress
Jianyi Zhu, Kaiwen Chen, Wenjuan Zhao, et al.
Annals of Translational Medicine
|
March 17, 2020
PITPNC1 fuels radioresistance of rectal cancer by inhibiting reactive oxygen species production
Yujing Tan, Ruoyang Shao, Jingyu Li, et al.
Page
of 5